Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.51 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.51 |
| ▸ | GABRP | O00591 | 2/20 | 0.50 |
| ▸ | GABRD | O14764 | 2/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.50 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.50 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.50 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.50 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.50 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.50 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.50 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.50 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.50 |
| ▸ | GABRE | P78334 | 2/20 | 0.50 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.50 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.50 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.50 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | GRM8 | O00222 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25246132 | 0.88 | DPP4 (0.47) | DPP4DPP9GABRPGABRDGABRA1 | |
| SCHEMBL18339143 | 0.88 | DPP4 (0.47) | DPP4DPP9GABRPGABRDGABRA1 | |
| SCHEMBL30050502 | 0.87 | DPP4 (0.50) | DPP4DPP9GABRPGABRDGABRA1 | |
| SCHEMBL18285489 | 0.87 | DPP4 (0.50) | DPP4DPP9GABRPGABRDGABRA1 | |
| SCHEMBL28606931 | 0.87 | DPP4 (0.50) | DPP4DPP9GABRPGABRDGABRA1 | |
| SCHEMBL3909782 | 0.85 | GRM8 (0.50) | DPP4DPP9GABRPGABRDGABRA1 | |
| SCHEMBL27719619 | 0.84 | ENPEP (0.50) | DPP4DPP9GABRPGABRDGABRA1 | |
| SCHEMBL441814 | 0.84 | ENPEP (0.50) | DPP4DPP9GABRPGABRDGABRA1 | |
| SCHEMBL28305160 | 0.81 | SLC1A3 (0.50) | DPP4DPP9GABRPGABRDGABRA1 | |
| SCHEMBL10795389 | 0.81 | GSR (0.52) | DPP4DPP9GABRPGABRDGABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4097145-B1 | REDUCTION OF ADSORPTION | LEUKOCARE AG (DE) | 2026-01-28 | — | — | EP | disclosed |
| US-12350375-B2 | Method for obtaining efficient viral vector-based compositions for vaccination or gene therapy | LEUKOCARE AG (DE) | 2025-07-08 | — | — | US | disclosed |
| US-20230225939-A1 | MEANS AND METHODS OF STERILIZATION OF BIOFUNCTIONAL COMPOSITIONS | LEUKOCARE AG (DE) | 2023-07-20 | — | — | US | disclosed |
| EP-3511336-B1 | METHOD FOR PREVENTING THE UNFOLDING OF A (POLY)PEPTIDE AND/OR INDUCING THE (RE-)FOLDING OF A (POLY)PEPTIDE | LEUKOCARE AG (DE) | 2023-06-21 | — | — | EP | disclosed |
| US-20230041240-A1 | Reduction of Adsorption | LEUKOCARE AG (DE) | 2023-02-09 | — | — | US | disclosed |
| EP-4097145-A1 | REDUCTION OF ADSORPTION | LEUKOCARE AG (DE) | 2022-12-07 | — | — | EP | disclosed |
| US-20220202717-A1 | Novel Method for Obtaining Efficient Viral Vector-Based Compositions for Vaccination or Gene Therapy | LEUKOCARE AG (DE) | 2022-06-30 | — | — | US | disclosed |
| EP-4013436-A1 | METHOD FOR OBTAINING EFFICIENT COMPOSITIONS COMPRISING VIRAL VECTORS FOR VACCINATION OR GENE THERAPY | LEUKOCARE AG (DE) | 2022-06-22 | — | — | EP | disclosed |
| WO-2021152121-A1 | REDUCTION OF ADSORPTION | LEUKOCARE AG (DE) | 2021-08-05 | — | — | WO | disclosed |
| WO-2021028559-A1 | METHOD FOR OBTAINING EFFICIENT COMPOSITIONS COMPRISING VIRAL VECTORS FOR VACCINATION OR GENE THERAPY | LEUKOCARE AG (DE) | 2021-02-18 | — | — | WO | disclosed |
| WO-2018050872-A1 | A NOVEL METHOD FOR OBTAINING EFFICIENT VIRAL VECTOR-BASED COMPOSITIONS FOR VACCINATION OR GENE THERAPY | LEUKOCARE AG (DE) | 2018-03-22 | — | — | WO | disclosed |
| EP-3060247-A1 | A NOVEL METHOD FOR THE PRODUCTION OF STABILE VACCINES | LEUKOCARE AG (DE) | 2016-08-31 | — | — | EP | disclosed |
| WO-2015128475-A1 | NOVEL COATED CARRIERS FOR THE SPECIFIC BINDING OF TARGET MOLECULES | LEUKOCARE AG (DE) | 2015-09-03 | — | — | WO | disclosed |
| WO-2015059284-A1 | A NOVEL METHOD FOR THE PRODUCTION OF STABILE VACCINES | LEUKOCARE AG (DE) | 2015-04-30 | — | — | WO | disclosed |
| EP-2794663-A1 | PEPTIDE THERAPEUTIC CONJUGATES AND USES THEREOF | Angiochem Inc. (CA) | 2014-10-29 | — | — | EP | disclosed |
| EP-2726495-A1 | METHOD FOR PREVENTING THE UNFOLDING OF A (POLY) PEPTIDE AND/OR INDUCING THE (RE- ) FOLDING OF A (POLY) PEPTIDE | LEUKOCARE AG (DE) | 2014-05-07 | — | — | EP | disclosed |
| EP-2726606-A1 | NOVEL STABILISATION METHOD FOR VIRUSES OR BACTERIA | LEUKOCARE AG (DE) | 2014-05-07 | — | — | EP | disclosed |
| WO-2013001034-A1 | NOVEL STABILISATION METHOD FOR VIRUSES OR BACTERIA | LEUKOCARE AG (DE) | 2013-01-03 | — | — | WO | disclosed |
| WO-2013001044-A1 | METHOD FOR PREVENTING THE UNFOLDING OF A (POLY) PEPTIDE AND/OR INDUCING THE (RE- ) FOLDING OF A (POLY) PEPTIDE | LEUKOCARE AG (DE) | 2013-01-03 | — | — | WO | disclosed |
| WO-2010063124-A1 | PEPTIDE THERAPEUTIC CONJUGATES AND USES THEREOF | ANGIOCHEM INC. (CA) | 2010-06-10 | — | — | WO | disclosed |